Meropenem Fresenius Kabi 1 g inj./inf. sol. (pwdr.) i.v. vial

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Meropenem Trihydrate 1140 mg - Eq. Meropenem 1000,1 mg

Commercializzato da:

Fresenius Kabi SA-NV

Codice ATC:

J01DH02

INN (Nome Internazionale):

Meropenem Trihydrate

Dosaggio:

1 g

Forma farmaceutica:

Powder for solution for injection/infusion

Composizione:

Meropenem Trihydrate 1140 mg

Via di somministrazione:

Intravenous use

Area terapeutica:

Meropenem

Dettagli prodotto:

CTI code: 374123-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834083 - Delivery mode: Medical prescription; CTI code: 374123-02 - Pack size: 10 x 1 g - Commercialisation status: NO - CNK code: 2825412 - Delivery mode: Medical prescription; CTI code: 374114-02 - Pack size: 10 x 1 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 374114-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834075 - Delivery mode: Medical prescription; CTI code: 374105-02 - Pack size: 10 x 1 g - Commercialisation status: YES - FMD code: 05425025650774 - CNK code: 2825412 - Delivery mode: Medical prescription; CTI code: 374105-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834067 - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: Yes

Data dell'autorizzazione:

2010-07-27